The diabetes-cardiovascular risk paradox: Results from a Finnish population-based prospective study

European Heart Journal

Volumn 29, Issue 15, 2008, Pages 1889-1895

  Barengo, Noël C ^a   Katoh, Shuichi ^a,b,c,d   Moltchanov, Vladislav ^b   Tajima, Naoko ^c   Tuomilehto, Jaakko ^a,e  

^a UNIVERSITY OF HELSINKI   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d Fuji City General Hospital   (Japan)

^e SOUTH OSTROBOTHNIA CENTRAL HOSPITAL   (Finland)

Author keywords

Coronary heart disease; Diabetes; Mortality; Population based study

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FINLAND; FOLLOW UP; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ADULT; BODY MASS INDEX; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; FINLAND; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; SMOKING;

EID: 48749098549     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehn250     Document Type: Article

References (40)

1. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998;21:1414-1431.
2. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-1053.
3. Kumanyika S, Jeffery RW, Morabia A, Ritenbaugh C, Antipatis VJ. Obesity prevention: the case for action. Int J Obes Relat Metab Disord 2002;26:425-436.
4. The DECODE Study Group. Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases. Diabetes Care 2003;26:688-696.
5. Goldbourt U, Yaasi S, Medalie JH. Factors predictive of long-term coronary heart disease mortality among 10,059 male Israeli civil servants and municipal employees. A 23-year mortality follow-up in the Israeli Ischemic Heart Disease Study. Cardiology 1993;82:100-121.
6. Medalie JH. Risk factors other than hyperglycemia in diabetic macrovascular disease. Diabetes Care 1979;2:77-84.
7. Medalie JH, Goldbourt U. Angina pectoris among 10,000 men. II. Psychosocial and other risk factors as evidenced by a multivariate analysis of a five year incidence study. Am J Med 1976;60:910-921.
8. Jousilahti P, Vartiainen E, Tuomilehto J, Pekkanen J, Puska P. Role of known risk factors in explaining the difference in the risk of coronary heart disease between eastern and southwestern Finland. Ann Med 1998;30:481-487.
9. Schernthaner G. Cardiovascular mortality and morbidity in type-2 diabetes mellitus. Diabetes Res Clin Pract 1996;31(suppl.):S3-S13.
10. Jousilahti P, Tuomilehto J, Korhonen H, Vartiainen E, Puska P, Nissinen A. Trends in cardiovascular disease risk factor clustering in eastern Finland: results of 15-year follow-up of the northern Karelia project. Prev Med 1994;23:6-14.
11. Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA 1979;241:2035-2038.
12. Thom TJ. International mortality from heart disease: rates and trends. Int J Epidemiol 1989;18(Suppl. 1):S20-S28.
13. Tuomilehto J, Puska P, Korhonen H, Mustaniemi H, Vartiainen E, Nissinen A, Kuulasmaa K, Niemensivu H, Salonen JT. Trends and determinants of ischaemic heart disease mortality in Finland: with special reference to a possible levelling off in the early 1980s. Int J Epidemiol 1989;18(Suppl. 1):S109-S117.
14. Vartiainen E, Korhonen HJ, Pietinen P, Tuomilehto J, Kartovaara L, Nissinen A, Puska P. Fifteen-year trends in coronary risk factors in Finland, with special reference to North Karelia. Int J Epidemiol 1991;20:651-662.
15. Kuulasmaa K, Tunstall-Pedoe H, Dobson A, Fortmann S, Sans S, Tolonen H, Evans A, Ferrario M, Tuomilehto J. Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations. Lancet 2000;355:675-687.
16. Gregg EW, Gu Q, Cheng YJ, Narayan KM, Cowie CC. Mortality trends in men and women with diabetes, 1971 to 2000. Ann Intern Med 2007;147:149-155.
17. Haffner SM. Epidemiological studies on the effects of hyperglycemia and improvement of glycemic control on macrovascular events in type 2 diabetes. Diabetes Care 1999;22:C54-C56.
18. Jousilahti P, Vartiainen E, Tuomilehto J, Puska P. Twenty-year dynamics of serum cholesterol levels in the middle-aged population of eastern Finland. Ann Intern Med 1996;125:713-722.
19. Jousilahti P, Vartiainen E, Pekkanen J, Tuomilehto J, Sundvall J, Puska P. Serum cholesterol distribution and coronary heart disease risk: observation and predictions among middle-aged population in eastern Finland. Circulation 1998;97:1087-1094.
20. The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major internal collaboration. J Clin Epidemiol 1988;41:105-114.
21. WHO Study Group on Diabetes Mellitus. Diabetes Mellitus: Report of a WHO Study Group. WHO Technical Report Series No. 727; 1985.
22. WHO Consultation. Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Part 1. Diagnosis and Classification of Diabetes Mellitus. Geneva: World Health Organisation; 1999.
23. Kahn HA, Sempos CT. Statistical Methods in Epidemiology. New York, NY: Oxford University Press; 1989. p. 217.
24. Cochran WG. Sampling Techniques. 3rd ed. New York, NY: John Wiley & Sons Inc.; 1977. p155.
25. European Diabetes Policy Group. Guidelines for diabetes care, a desktop guide to type 2 diabetes mellitus. Diabet Med 1999;16:15-16.
26. Thomas RJ, Palumbo PJ, Melton LJ III, Roger VL, Ransom J, O'Brien PC, Leibson CL. Trends in the mortality burden associated with diabetes mellitus: a population-based study in Rochester, Minn., 1970-1994. Arch Intern Med 2003;163:445-451.
27. Fox CS, Coady S, Sorlie PD, Levy D, Meigs JB, D'Agostino RB Sr, Wilson PW, Savage PJ. Trends in cardiovascular complications of diabetes. JAMA 2004;292:2495-2499.
28. Salomaa V, Ketonen M, Koukkunen H, Immonen-Raiha P, Jerkkola T, Karja-Koskenkari P, Mahonen M, Niemela M, Kuulasmaa K, Palomaki P, Arstila M, Vuorenmaa T, Lehtonen A, Lehto S, Miettinen H, Torppa J, Tuomilehto J, Kesaniemi YA, Pyorala K. Trends in coronary events in Finland during 1983-1997. The FINAMI study. Eur Heart J 2003;24:311-319.
29. Salomaa V, Miettinen H, Kuulasmaa K, Niemela M, Ketonen M, Vuorenmaa T, Lehto S, Palomaki P, Mahonen M, Immonen-Raiha P, Arstila M, Kaarsalo E, Mustaniemi H, Torppa J, Tuomilehto J, Puska P, Pyorala K. Decline of coronary heart disease mortality in Finland during 1983 to 1992: roles of incidence, recurrence, and case-fatality. The FINMONICA MI Register Study. Circulation 1996;94:3130-3137.
30. Mahonen M, Salomaa V, Keskimaki I, Moltchanov V. The feasibility of routine mortality and morbidity register data linkage to study the occurrence of acute coronary heart disease events in Finland. The Finnish Cardiovascular Disease Registers (CVDR) Project. Eur J Epidemiol 2000;16:701-711.
31. Miettinen H, Lehto S, Salomaa V, Mahonen M, Niemela M, Haffner SM, Pyorala K, Tuomilehto J. Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group. Diabetes Care 1998;21:69-75.
32. Bartnik M, Ryden L, Ferrari R, Malmberg K, Pyorala K, Simoons M, Standl E, Soler-Soler J, Ohrvik J, Euro Heart Survey Investigators. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart. Eur Heart J 2004;25:1880-1890.
33. The DECODE Study Group, European Diabetes Epidemiology Group. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. Lancet 1999;354:617-621.
34. DECODE Study Group, the European Diabetes Epidemiology Group. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2 h diagnostic criteria. Arch Intern Med 2001;161:397-405.
35. Qiao Q, Tuomilehto J, Borch-Johnsen K. Post-challenge hyperglycaemia is associated with premature death and macrovascular complications. Diabetologia 2003;46(Suppl. 1):M17-M21.
36. Hu G, Jousilahti P, Qiao Q, Peltonen M, Katoh S, Tuomilehto J. The gender-specific impact of diabetes and myocardial infarction at baseline and during follow-up on mortality from all causes and coronary heart disease. J Am Coll Cardiol 2005;45:1413-1418.
37. Lloyd CE, Kuller LH, Ellis D, Becker DJ, Wing RR, Orchard TJ. Coronary artery disease in IDDM. Gender differences in risk factors but not risk. Arterioscler Thromb Vasc Biol 1996;16:720-726.
38. Hu G, Jousilahti P, Qiao Q, Katoh S, Tuomilehto J. Sex differences in cardiovascular and total mortality among diabetic and non-diabetic individuals with or without history of myocardial infarction. Diabetologia 2005;48:856-861.
39. Turner RC, Millns H, Neil HA, Stratton IM, Manley SE, Matthews DR, Holman RR. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23). Br Med J 1998;316:823-828.
40. Hu G, Jousilahti P, Barengo NC, Qiao Q, Lakka TA, Tuomilehto J. Physical activity, cardiovascular risk factors, and mortality among Finnish adults with diabetes. Diabetes Care 2005;28:799-805.